Literature DB >> 23562878

Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.

Shi-Yun Cui1, Jia-Yuan Huang, Yi-Tian Chen, Hai-Zhu Song, Bing Feng, Gui-Chun Huang, Rui Wang, Long-Bang Chen, Wei De.   

Abstract

MicroRNA (miRNA) expression and functions have been reported to contribute to phenotypic features of tumor cells. Although targets and functional roles for many miRNAs have been described in lung adenocarcinoma (LAD), their pathophysiologic roles in phenotypes of chemoresistant LAD cells are still largely unclear. Previously, docetaxel (DTX)-resistant LAD cell lines (SPC-A1/DTX and H1299/DTX) were established by our laboratory and displayed chemo- or radioresistance and mesenchymal features with enhanced invasiveness and motility. Unbiased miRNA profiling indicated that let-7c (MIRLET7C) was significantly downregulated in SPC-A1/DTX cells. Ectopic let-7c expression increased the in vitro and in vivo chemo- or radiosensitivity of DTX-resistant LAD cells through enhanced apoptosis, reversal of epithelial-to-mesenchymal phenotypes, and inhibition of in vivo metastatic potential via inactivation of Akt phosphorylation, whereas a let-7c inhibitor decreased the chemo- or radiosensitivity of parental cells. Further investigation suggested that let-7c significantly reduced the luciferase activity of a Bcl-xL 3'-UTR-based reporter, concordant with reduced Bcl-xL protein levels. Additionally, siRNA-mediated Bcl-xL knockdown mimicked the same effects of let-7c precursor, and enforced Bcl-xL expression partially rescued the effects of let-7c precursor in DTX-resistant LAD cells. Furthermore, we found that Bcl-xL was significantly upregulated in DTX-nonresponding LAD tissues, and its expression was inversely correlated with let-7c expression. This study suggests an important role for let-7c in the molecular etiology of chemoresistant lung adenocarcinoma. ©2013 AACR

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23562878     DOI: 10.1158/1541-7786.MCR-13-0019-T

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  26 in total

1.  Role of miR-100 in the radioresistance of colorectal cancer cells.

Authors:  Xiao-Dong Yang; Xiao-Hui Xu; Shu-Yu Zhang; Yong Wu; Chun-Gen Xing; Gan Ru; Hong-Tao Xu; Jian-Ping Cao
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 2.  miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Authors:  Mateusz Florczuk; Adam Szpechcinski; Joanna Chorostowska-Wynimko
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

Review 3.  microRNAs and cancer metabolism reprogramming: the paradigm of metformin.

Authors:  Claudio Pulito; Sara Donzelli; Paola Muti; Luisa Puzzo; Sabrina Strano; Giovanni Blandino
Journal:  Ann Transl Med       Date:  2014-06

4.  Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.

Authors:  Ramzi M Mohammad; Yiwei Li; Irfana Muqbil; Amro Aboukameel; William Senapedis; Erkan Baloglu; Yosef Landesman; Philip A Philip; Asfar S Azmi
Journal:  Small GTPases       Date:  2017-06-23

5.  MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment.

Authors:  Bing-Yuan Fei; Xiu-Ying Wang; Xue-Dong Fang
Journal:  Tumour Biol       Date:  2015-11-18

6.  MicroRNA-650 was a prognostic factor in human lung adenocarcinoma and confers the docetaxel chemoresistance of lung adenocarcinoma cells via regulating Bcl-2/Bax expression.

Authors:  Jia-Yuan Huang; Shi-Yun Cui; Yi-Tian Chen; Hai-Zhu Song; Gui-Chun Huang; Bing Feng; Ming Sun; Wei De; Rui Wang; Long-Bang Chen
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

7.  Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy.

Authors:  Xin Dai; Ying Jiang; Chalet Tan
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

8.  MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.

Authors:  Jia-Yuan Huang; Kai Zhang; Dong-Qin Chen; Jing Chen; Bing Feng; Haizhu Song; Yitian Chen; Ziman Zhu; Lei Lu; Wei De; Rui Wang; Long-Bang Chen
Journal:  Oncotarget       Date:  2015-07-30

9.  Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs.

Authors:  Aamir Ahmad; Ma'in Y Maitah; Kevin R Ginnebaugh; Yiwei Li; Bin Bao; Shirish M Gadgeel; Fazlul H Sarkar
Journal:  J Hematol Oncol       Date:  2013-10-07       Impact factor: 17.388

Review 10.  Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.

Authors:  Fei Guo; Brittany C Parker Kerrigan; Da Yang; Limei Hu; Ilya Shmulevich; Anil K Sood; Fengxia Xue; Wei Zhang
Journal:  J Hematol Oncol       Date:  2014-03-05       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.